1. Home
  2. IMMP vs INDO Comparison

IMMP vs INDO Comparison

Compare IMMP & INDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immutep Limited

IMMP

Immutep Limited

HOLD

Current Price

$0.36

Market Cap

58.2M

Sector

Health Care

ML Signal

HOLD

Logo Indonesia Energy Corporation Limited

INDO

Indonesia Energy Corporation Limited

HOLD

Current Price

$3.75

Market Cap

69.4M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMMP
INDO
Founded
1987
2018
Country
Australia
Indonesia
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
58.2M
69.4M
IPO Year
2012
2018

Fundamental Metrics

Financial Performance
Metric
IMMP
INDO
Price
$0.36
$3.75
Analyst Decision
Hold
Analyst Count
3
0
Target Price
$5.50
N/A
AVG Volume (30 Days)
3.3M
4.3M
Earning Date
04-23-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$382.75
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.35
$2.21
52 Week High
$3.53
$8.50

Technical Indicators

Market Signals
Indicator
IMMP
INDO
Relative Strength Index (RSI) 13.40 43.00
Support Level N/A $2.72
Resistance Level $1.90 $5.12
Average True Range (ATR) 0.06 0.37
MACD -0.05 -0.11
Stochastic Oscillator 0.28 8.42

Price Performance

Historical Comparison
IMMP
INDO

About IMMP Immutep Limited

Immutep Ltd is a Phase three clinical biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate the body's immune response to fight cancer or suppress the immune system to treat autoimmune disease. The company is focused on advancing its product candidate, eftilagimod alfa (efti), through its registrational Phase three clinical trial towards marketing approval in first-line non-small cell lung cancer (1L NSCLC). The other product candidates in its portfolio include TACTI-004, TACTI-003, AIPAC-003, TACTI-002, INSIGHT-005, and others, being developed as potential therapies for various cancers and autoimmune diseases.

About INDO Indonesia Energy Corporation Limited

Indonesia Energy Corp Ltd is an oil and gas exploration and production company focused on Indonesia. The company is an independent energy company engaged in the oil and gas business and holds two oil and gas assets through its subsidiaries in Indonesia: The Kruh Block and the Citarum Block. It has also identified a potential third exploration block known as the Rangkas area. . Its portfolio consists of Kruh Block and Citarum Block. The company generates its revenue from oil and gas sales.

Share on Social Networks: